Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment

M. Köllensperger, M. Stampfer-Kountchev, K. Seppi, F. Geser, C. Frick, F. Del Sorbo, A. Albanese, T. Gurevich, N. Giladi, R. Djaldetti, A. Schrag, P. A. Low, C. J. Mathias, W. Poewe, G. K. Wenning

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

To assess severity and progression of self-perceived dysautonomia and their impact on health-related quality of life (Hr-QoL) in multiple system atrophy (MSA), twenty-seven patients were recruited by the European MSA Study Group (EMSA-SG). At baseline, all patients completed the Composite Autonomic Symptom Scale (COMPASS) and the 36 item Short Form Health Survey (SF-36), and they were assessed using the 3-point global disease severity scale (SS-3) and the Unified MSA Rating Scale (UMSARS). After 6 months follow-up, the self completed COMPASS Change Scale (CCS), the SF-36, SS-3, and UMSARS were obtained. MSA patients showed marked self-perceived dysautonomia at baseline visit and pronounced worsening of dysautonomia severity on the CCS at follow-up. Severity and progression of dysautonomia did not correlate with age, disease duration, motor impairment and overall disease severity at baseline. There were no significant differences between genders and motor subtypes. Baseline COMPASS scores were, however, inversely correlated with SF-36 scores. Progression of self-perceived dysautonomia did not correlate with global disease progression. Hr-QoL scores were stable during follow-up. This is the first study to investigate self-perceived dysautonomia severity in MSA and its evolution over time. Our data suggest that dysautonomia should be recognized as a key target for therapeutic intervention in MSA.

Original languageEnglish
Pages (from-to)66-72
Number of pages7
JournalEuropean Journal of Neurology
Volume14
Issue number1
DOIs
Publication statusPublished - Jan 2007

Fingerprint

Primary Dysautonomias
Multiple System Atrophy
Prospective Studies
Quality of Life
Health Surveys
Disease Progression

Keywords

  • Composite Autonomic Symptom Scale
  • Dysautonomia
  • Health-related quality of life
  • Multiple system atrophy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Köllensperger, M., Stampfer-Kountchev, M., Seppi, K., Geser, F., Frick, C., Del Sorbo, F., ... Wenning, G. K. (2007). Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment. European Journal of Neurology, 14(1), 66-72. https://doi.org/10.1111/j.1468-1331.2006.01554.x

Progression of dysautonomia in multiple system atrophy : A prospective study of self-perceived impairment. / Köllensperger, M.; Stampfer-Kountchev, M.; Seppi, K.; Geser, F.; Frick, C.; Del Sorbo, F.; Albanese, A.; Gurevich, T.; Giladi, N.; Djaldetti, R.; Schrag, A.; Low, P. A.; Mathias, C. J.; Poewe, W.; Wenning, G. K.

In: European Journal of Neurology, Vol. 14, No. 1, 01.2007, p. 66-72.

Research output: Contribution to journalArticle

Köllensperger, M, Stampfer-Kountchev, M, Seppi, K, Geser, F, Frick, C, Del Sorbo, F, Albanese, A, Gurevich, T, Giladi, N, Djaldetti, R, Schrag, A, Low, PA, Mathias, CJ, Poewe, W & Wenning, GK 2007, 'Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment', European Journal of Neurology, vol. 14, no. 1, pp. 66-72. https://doi.org/10.1111/j.1468-1331.2006.01554.x
Köllensperger, M. ; Stampfer-Kountchev, M. ; Seppi, K. ; Geser, F. ; Frick, C. ; Del Sorbo, F. ; Albanese, A. ; Gurevich, T. ; Giladi, N. ; Djaldetti, R. ; Schrag, A. ; Low, P. A. ; Mathias, C. J. ; Poewe, W. ; Wenning, G. K. / Progression of dysautonomia in multiple system atrophy : A prospective study of self-perceived impairment. In: European Journal of Neurology. 2007 ; Vol. 14, No. 1. pp. 66-72.
@article{668721dec2bd4bfab9299c8493a7bd30,
title = "Progression of dysautonomia in multiple system atrophy: A prospective study of self-perceived impairment",
abstract = "To assess severity and progression of self-perceived dysautonomia and their impact on health-related quality of life (Hr-QoL) in multiple system atrophy (MSA), twenty-seven patients were recruited by the European MSA Study Group (EMSA-SG). At baseline, all patients completed the Composite Autonomic Symptom Scale (COMPASS) and the 36 item Short Form Health Survey (SF-36), and they were assessed using the 3-point global disease severity scale (SS-3) and the Unified MSA Rating Scale (UMSARS). After 6 months follow-up, the self completed COMPASS Change Scale (CCS), the SF-36, SS-3, and UMSARS were obtained. MSA patients showed marked self-perceived dysautonomia at baseline visit and pronounced worsening of dysautonomia severity on the CCS at follow-up. Severity and progression of dysautonomia did not correlate with age, disease duration, motor impairment and overall disease severity at baseline. There were no significant differences between genders and motor subtypes. Baseline COMPASS scores were, however, inversely correlated with SF-36 scores. Progression of self-perceived dysautonomia did not correlate with global disease progression. Hr-QoL scores were stable during follow-up. This is the first study to investigate self-perceived dysautonomia severity in MSA and its evolution over time. Our data suggest that dysautonomia should be recognized as a key target for therapeutic intervention in MSA.",
keywords = "Composite Autonomic Symptom Scale, Dysautonomia, Health-related quality of life, Multiple system atrophy",
author = "M. K{\"o}llensperger and M. Stampfer-Kountchev and K. Seppi and F. Geser and C. Frick and {Del Sorbo}, F. and A. Albanese and T. Gurevich and N. Giladi and R. Djaldetti and A. Schrag and Low, {P. A.} and Mathias, {C. J.} and W. Poewe and Wenning, {G. K.}",
year = "2007",
month = "1",
doi = "10.1111/j.1468-1331.2006.01554.x",
language = "English",
volume = "14",
pages = "66--72",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Progression of dysautonomia in multiple system atrophy

T2 - A prospective study of self-perceived impairment

AU - Köllensperger, M.

AU - Stampfer-Kountchev, M.

AU - Seppi, K.

AU - Geser, F.

AU - Frick, C.

AU - Del Sorbo, F.

AU - Albanese, A.

AU - Gurevich, T.

AU - Giladi, N.

AU - Djaldetti, R.

AU - Schrag, A.

AU - Low, P. A.

AU - Mathias, C. J.

AU - Poewe, W.

AU - Wenning, G. K.

PY - 2007/1

Y1 - 2007/1

N2 - To assess severity and progression of self-perceived dysautonomia and their impact on health-related quality of life (Hr-QoL) in multiple system atrophy (MSA), twenty-seven patients were recruited by the European MSA Study Group (EMSA-SG). At baseline, all patients completed the Composite Autonomic Symptom Scale (COMPASS) and the 36 item Short Form Health Survey (SF-36), and they were assessed using the 3-point global disease severity scale (SS-3) and the Unified MSA Rating Scale (UMSARS). After 6 months follow-up, the self completed COMPASS Change Scale (CCS), the SF-36, SS-3, and UMSARS were obtained. MSA patients showed marked self-perceived dysautonomia at baseline visit and pronounced worsening of dysautonomia severity on the CCS at follow-up. Severity and progression of dysautonomia did not correlate with age, disease duration, motor impairment and overall disease severity at baseline. There were no significant differences between genders and motor subtypes. Baseline COMPASS scores were, however, inversely correlated with SF-36 scores. Progression of self-perceived dysautonomia did not correlate with global disease progression. Hr-QoL scores were stable during follow-up. This is the first study to investigate self-perceived dysautonomia severity in MSA and its evolution over time. Our data suggest that dysautonomia should be recognized as a key target for therapeutic intervention in MSA.

AB - To assess severity and progression of self-perceived dysautonomia and their impact on health-related quality of life (Hr-QoL) in multiple system atrophy (MSA), twenty-seven patients were recruited by the European MSA Study Group (EMSA-SG). At baseline, all patients completed the Composite Autonomic Symptom Scale (COMPASS) and the 36 item Short Form Health Survey (SF-36), and they were assessed using the 3-point global disease severity scale (SS-3) and the Unified MSA Rating Scale (UMSARS). After 6 months follow-up, the self completed COMPASS Change Scale (CCS), the SF-36, SS-3, and UMSARS were obtained. MSA patients showed marked self-perceived dysautonomia at baseline visit and pronounced worsening of dysautonomia severity on the CCS at follow-up. Severity and progression of dysautonomia did not correlate with age, disease duration, motor impairment and overall disease severity at baseline. There were no significant differences between genders and motor subtypes. Baseline COMPASS scores were, however, inversely correlated with SF-36 scores. Progression of self-perceived dysautonomia did not correlate with global disease progression. Hr-QoL scores were stable during follow-up. This is the first study to investigate self-perceived dysautonomia severity in MSA and its evolution over time. Our data suggest that dysautonomia should be recognized as a key target for therapeutic intervention in MSA.

KW - Composite Autonomic Symptom Scale

KW - Dysautonomia

KW - Health-related quality of life

KW - Multiple system atrophy

UR - http://www.scopus.com/inward/record.url?scp=33846179348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846179348&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2006.01554.x

DO - 10.1111/j.1468-1331.2006.01554.x

M3 - Article

C2 - 17222116

AN - SCOPUS:33846179348

VL - 14

SP - 66

EP - 72

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 1

ER -